Intimation w.r.t Closure of Trading Window

Date: 25.09.2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai – 400001 Dear Sir/Madam, BSE Scrip: PHARMAID | Code: 524572 | ISIN: INE117D01018 Sub: Intimation of Closure of Trading Window as per SEBI (Prohibition of Insider Trading) Regulations, 2015 Pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company’s Code of Conduct and Policies for Prevention of Insider Trading, the Trading Window for the Designated Persons and their Immediate relatives dealing in the Securities of the Company will be closed from October 01, 2026 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026. The date of the Board Meeting for consideration of the Unaudited Financial Results of the Company for the quarter and half year ended 30th September 2026 shall be intimated in due course of time. This information will also be made available on the Company’s website at www.pharmaids.com You are requested to take the above information on record For Pharmaids Pharmaceuticals Limited Prasanna Subramanya Bhat (Company Secretary & Compliance officer) PHARMAIDS PHARMACEUTICALS LIMITED (CIN: L52520KA1989PLC173979) Registered Office.: Unit #201, Brigade Rubix, 20/14, HMT Factory Road, Peenya Plantation, Bangalore 560013 INDIA Phone: 080-49784319 Email: compliance@pharmaids.com WEB: www.pharmaids.com